We're proud to announce a new partnership between the National Senior Games Association and the Heartline™ Study. The Heartline Study is a virtual research study from Johnson & Johnson in collaboration with Apple. The study aims to analyze the impact of an app-based heart health engagement program on the early detection of irregular heart rhythms consistent with atrial fibrillation (AFib), and the potential to improve heart health outcomes, including reducing the risk of stroke and other cardiovascular conditions.
Approximately six million people in the United States live with AFib, and up to 30% don’t even know they have it until a serious cardiovascular event, such as stroke, occurs because it is often not associated with any symptoms.
In an effort to change this through an app-based approach, the Heartline Study will enable participants to engage in the study remotely from home, right from their iPhone and in some cases with an Apple Watch, rather than travel to a clinical study site. Individuals with and without a diagnosis of AFib are eligible to join. The study also provides a rich engagement program with activities that may help improve your sleep, fitness and wellness and help you become more engaged in your overall heart health. Individuals with and without a diagnosis of AFib are eligible to join.
There are a variety of ways to participate in the Heartline Study. All who join will need to have an iPhone 6s or newer. Some participants will take part using only their iPhone. Some participants will also be asked to wear an Apple Watch. Those asked to wear a watch will be offered two options: purchase one, or get one on loan for the duration of the study and return it when your participation in the study ends. Johnson & Johnson and Apple are committed to ensuring that participation in the study is not limited based on financial need.
Through this new partnership, the NSGA will be sharing news about the virtual study and information about how you can get involved. In the meantime, visit Heartline.com to learn more.*